Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

28 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Smoldering and polarized inflammation in the initiation and promotion of malignant disease.
Balkwill F, Charles KA, Mantovani A. Balkwill F, et al. Among authors: charles ka. Cancer Cell. 2005 Mar;7(3):211-7. doi: 10.1016/j.ccr.2005.02.013. Cancer Cell. 2005. PMID: 15766659 Review. No abstract available.
A dynamic inflammatory cytokine network in the human ovarian cancer microenvironment.
Kulbe H, Chakravarty P, Leinster DA, Charles KA, Kwong J, Thompson RG, Coward JI, Schioppa T, Robinson SC, Gallagher WM, Galletta L; Australian Ovarian Cancer Study Group, Salako MA, Smyth JF, Hagemann T, Brennan DJ, Bowtell DD, Balkwill FR. Kulbe H, et al. Among authors: charles ka. Cancer Res. 2012 Jan 1;72(1):66-75. doi: 10.1158/0008-5472.CAN-11-2178. Epub 2011 Nov 7. Cancer Res. 2012. PMID: 22065722 Free PMC article.
The tumor-promoting actions of TNF-alpha involve TNFR1 and IL-17 in ovarian cancer in mice and humans.
Charles KA, Kulbe H, Soper R, Escorcio-Correia M, Lawrence T, Schultheis A, Chakravarty P, Thompson RG, Kollias G, Smyth JF, Balkwill FR, Hagemann T. Charles KA, et al. J Clin Invest. 2009 Oct;119(10):3011-23. doi: 10.1172/JCI39065. Epub 2009 Sep 8. J Clin Invest. 2009. PMID: 19741298 Free PMC article.
Tumour necrosis factor-alpha as a tumour promoter.
Szlosarek P, Charles KA, Balkwill FR. Szlosarek P, et al. Among authors: charles ka. Eur J Cancer. 2006 Apr;42(6):745-50. doi: 10.1016/j.ejca.2006.01.012. Epub 2006 Mar 6. Eur J Cancer. 2006. PMID: 16517151 Review.
Ovarian cancer cell-derived migration inhibitory factor enhances tumor growth, progression, and angiogenesis.
Hagemann T, Robinson SC, Thompson RG, Charles K, Kulbe H, Balkwill FR. Hagemann T, et al. Among authors: charles k. Mol Cancer Ther. 2007 Jul;6(7):1993-2002. doi: 10.1158/1535-7163.MCT-07-0118. Mol Cancer Ther. 2007. PMID: 17620429
Macrophages induce invasiveness of epithelial cancer cells via NF-kappa B and JNK.
Hagemann T, Wilson J, Kulbe H, Li NF, Leinster DA, Charles K, Klemm F, Pukrop T, Binder C, Balkwill FR. Hagemann T, et al. Among authors: charles k. J Immunol. 2005 Jul 15;175(2):1197-205. doi: 10.4049/jimmunol.175.2.1197. J Immunol. 2005. PMID: 16002723
Inflammation and cancer: causes and consequences.
Moore MM, Chua W, Charles KA, Clarke SJ. Moore MM, et al. Among authors: charles ka. Clin Pharmacol Ther. 2010 Apr;87(4):504-8. doi: 10.1038/clpt.2009.254. Epub 2010 Feb 10. Clin Pharmacol Ther. 2010. PMID: 20147899 Review.
Ovarian cancer cells polarize macrophages toward a tumor-associated phenotype.
Hagemann T, Wilson J, Burke F, Kulbe H, Li NF, Pl├╝ddemann A, Charles K, Gordon S, Balkwill FR. Hagemann T, et al. Among authors: charles k. J Immunol. 2006 Apr 15;176(8):5023-32. doi: 10.4049/jimmunol.176.8.5023. J Immunol. 2006. PMID: 16585599
"Re-educating" tumor-associated macrophages by targeting NF-kappaB.
Hagemann T, Lawrence T, McNeish I, Charles KA, Kulbe H, Thompson RG, Robinson SC, Balkwill FR. Hagemann T, et al. Among authors: charles ka. J Exp Med. 2008 Jun 9;205(6):1261-8. doi: 10.1084/jem.20080108. Epub 2008 May 19. J Exp Med. 2008. PMID: 18490490 Free PMC article.
The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer.
Guthrie GJ, Charles KA, Roxburgh CS, Horgan PG, McMillan DC, Clarke SJ. Guthrie GJ, et al. Among authors: charles ka. Crit Rev Oncol Hematol. 2013 Oct;88(1):218-30. doi: 10.1016/j.critrevonc.2013.03.010. Epub 2013 Apr 17. Crit Rev Oncol Hematol. 2013. PMID: 23602134 Review.
28 results
Jump to page